CTOs on the Move

BayCare Clinic

www.baycareclinic.com

 
BayCare Clinic is a physician-owned specialty care clinic based in Green Bay, Wisconsin, that offers expertise in more than 20 specialties with over 100 physicians serving in 16 area communities. BayCare Clinic is a joint partner in Aurora BayCare Medi...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

TrialCard

TrialCard offers customized patient access solutions exclusively for the pharmaceutical industry in support of product marketing, patient assistance programs, and phase IV clinical trials. TrialCard innovates by focusing on client brands and analyzing new trends in prescription optimization for both insured, and uninsured patients.

EPBS-Intermedix

Medical Consultants, Inc. is the largest independent provider of medical billing and coding services to emergency room physician groups in the United States. The Company provides a full outsourced billing solution, including data capture, transcription,

NYU Langone Medical Center

NYU Langone Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about NYU Langone Medical Center, please visit www.nyumc.org

Nursefinders

Nursefinders is one of the nation's largest medical staffing and specialty home health care companies providing RNs, LPN/LVNs, therapists, nursing assistants, home health aides, companions and other health care and medical clerical professionals. We

Diagnocure

DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.